Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481416 · ClinicalTrials.gov registry record
"Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 318
- Enrollment target
NCT00481416: Completed study, sponsored by Medtronic - MITG.
NCT00481416 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 318 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00481416 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 318 participants
- Enrollment target
Study Summary
The purpose of the study is to access the accuracy of the PillCam Eso capsule in identifying the presence of suspected esophageal disease in patients undergoing surveillance or screening for esophageal disease by standard endoscopy
Interventions
- DEVICE PillCam Eso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-01 |
What the finished NCT00481416 record still lists
NCT00481416 is an observational study that tracks outcomes without assigning an intervention. The registered 318 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which PillCam Eso is the first listed.
NCT00481416 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00481416 about?
NCT00481416 is a clinical study titled ""Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices". The purpose of the study is to access the accuracy of the PillCam Eso capsule in identifying the presence of suspected esophageal disease in patients undergoing surveillance or screening for esophageal disease by standard endoscopy
What is the current status of trial NCT00481416?
This trial is currently completed. The enrollment target is 318 participants. The study started on 2004-12. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00481416?
The interventions under investigation include: PillCam Eso (DEVICE).
Who is sponsoring clinical trial NCT00481416?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
- NCT05675735 · 318 participants · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
- NCT05895786 · 318 participants · Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NCT06051617 · 318 participants · Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia